Related Experiment Videos

Thymomodulin increases release of granulocyte-macrophage colony stimulating factor and of tumour necrosis factor in

B Balbi1, M T Valle, S Oddera

  • 1Interuniversity Center for Lung Diseases of Northern Italy, Milan.

Insights

Thymomodulin (TMD) enhances immune responses by stimulating lymphocytes to release granulocyte macrophage colony-stimulating factor (GM-CSF). It also modulates macrophage-lymphocyte interactions, increasing tumour necrosis factor (TNF) and GM-CSF release.

Area of Science:

  • Immunology
  • Pharmacology

Background:

  • Thymomodulin (TMD) is a thymic biological response modifier.
  • Cytokines play crucial roles in lung immune reactions.

Purpose of the Study:

  • To evaluate TMD's effects on cytokine release from human alveolar macrophages (AM) and peripheral blood lymphocytes (PBL).

Main Methods:

  • Human AM and PBL were cultured alone and in co-cultures.
  • Cytokine levels (gamma-IFN, IL-1, TNF, GM-CSF) were measured after TMD treatment.

Main Results:

  • TMD increased tumour necrosis factor (TNF) and granulocyte macrophage colony-stimulating factor (GM-CSF) in AM-PBL co-cultures.
  • TMD alone stimulated PBL to secrete increased GM-CSF.
  • TMD did not affect cytokine release from AM alone.

Conclusions:

  • TMD directly stimulates lymphocytes to secrete GM-CSF.
  • TMD modulates macrophage-lymphocyte interactions, influencing TNF and GM-CSF release.

Related Concept Videos